Correlation Between Vaccibody and Dow Jones
Can any of the company-specific risk be diversified away by investing in both Vaccibody and Dow Jones at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccibody and Dow Jones into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccibody As and Dow Jones Industrial, you can compare the effects of market volatilities on Vaccibody and Dow Jones and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccibody with a short position of Dow Jones. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccibody and Dow Jones.
Diversification Opportunities for Vaccibody and Dow Jones
Pay attention - limited upside
The 3 months correlation between Vaccibody and Dow is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Vaccibody As and Dow Jones Industrial in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dow Jones Industrial and Vaccibody is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccibody As are associated (or correlated) with Dow Jones. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dow Jones Industrial has no effect on the direction of Vaccibody i.e., Vaccibody and Dow Jones go up and down completely randomly.
Pair Corralation between Vaccibody and Dow Jones
If you would invest (100.00) in Vaccibody As on December 23, 2024 and sell it today you would earn a total of 100.00 from holding Vaccibody As or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Vaccibody As vs. Dow Jones Industrial
Performance |
Timeline |
Vaccibody and Dow Jones Volatility Contrast
Predicted Return Density |
Returns |
Vaccibody As
Pair trading matchups for Vaccibody
Dow Jones Industrial
Pair trading matchups for Dow Jones
Pair Trading with Vaccibody and Dow Jones
The main advantage of trading using opposite Vaccibody and Dow Jones positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccibody position performs unexpectedly, Dow Jones can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dow Jones will offset losses from the drop in Dow Jones' long position.Vaccibody vs. Molecular Partners AG | Vaccibody vs. MediciNova | Vaccibody vs. Anebulo Pharmaceuticals | Vaccibody vs. Champions Oncology |
Dow Jones vs. Flanigans Enterprises | Dow Jones vs. McDonalds | Dow Jones vs. El Pollo Loco | Dow Jones vs. Dominos Pizza Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |